Cafepharma Today

July 26 2024 - Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
BMS gets Q2 beat, raises full-year guidance as cost-cutting initiative continues
Big Pharma appears to be unfazed by IRA drug price negotiations
Indivior reaches $86 million opioid settlement with US states
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche Keeps Pressing; Amid Frustration, CEO Is Confident Genentech Deal Will Get Done
WSJ Online
Monday, February 9, 2009 - 10:35am
tags:
Roche, Genentech, buyouts
Indevus gel meets safety goal, hints at prevention
Yahoo/AP
Monday, February 9, 2009 - 10:33am
tags:
Indevus, HIV
Ligand Earns $1 Million Milestone Payment on Progress of Drug Candidate for Alzheimer's Disease
Yahoo
Monday, February 9, 2009 - 9:46am
tags:
Ligand, Alzheimer's disease, Schering Plough
J&J files multiple applications for antipsychotic drugs
Trading Markets
Monday, February 9, 2009 - 9:45am
tags:
JNJ, antipsychotics
KV cuts 700 jobs
Bizjournals
Monday, February 9, 2009 - 9:44am
tags:
KV Pharmaceutical, layoffs
Viropharma CMV Drug Data Disappoint
TheStreet.com
Monday, February 9, 2009 - 9:41am
tags:
CMV, ViroPharma, maribavir
SciClone Issues Guidance, Breaking Through to Profitability for the Full Year of 2009
Yahoo
Monday, February 9, 2009 - 9:39am
tags:
SciClone
Lundbeck Surges as $900 Million Takeover Adds Foothold in U.S.
Bloomberg
Monday, February 9, 2009 - 9:39am
tags:
Lundbeck, Ovation, buyouts
AstraZeneca licenses potential antidepressants
Yahoo/AP
Monday, February 9, 2009 - 9:09am
tags:
AstraZeneca, liscensing, antidepressants
Bristol Myers Is the Icing on Mead Johnson Nutrition's IPO
Seeking Alpha
Monday, February 9, 2009 - 9:09am
tags:
Mead Johnson, IPOs, Bristol-Myers Squibb
AP IMPACT: Drugmakers' push boosts 'murky' ailment
Yahoo/AP
Monday, February 9, 2009 - 9:08am
tags:
fibromyalgia, Eli Lilly, Pfizer
Elan investors urge change at top
FT.com
Monday, February 9, 2009 - 9:07am
tags:
Elan
China Biotech in Review: Cautious Optimism
Seeking Alpha
Sunday, February 8, 2009 - 12:42pm
tags:
China, biotech
Biotech Outperforms Pharmaceuticals
Seeking Alpha
Sunday, February 8, 2009 - 12:40pm
tags:
biotech
Tough Love for Biotech Industry
Seeking Alpha
Sunday, February 8, 2009 - 12:35pm
tags:
biotech
IMPAX Receives Final FDA Approval For Generic SOLODYN Extended-Release Tablets, 45mg, 90mg And 135mg
Medical News Today
Sunday, February 8, 2009 - 12:22pm
tags:
Impax
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
Ad Hoc News, Germany
Sunday, February 8, 2009 - 12:20pm
tags:
CollaGenex Pharmaceuticals, Galderma
Piramal Health says Glaxo, Sanofi acquisition reports unfounded
Yahoo
Sunday, February 8, 2009 - 12:17pm
tags:
Piramal Healthcare, GSK, Sanofi
Icahn: Biotechs For Sale
Forbes
Sunday, February 8, 2009 - 12:15pm
tags:
biotech, Carl Icahn
Idenix lands $434M licensing deal
Bizjournals.com
Saturday, February 7, 2009 - 12:25pm
tags:
Idenix

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Crafting Effective, Patient-Centric Channel Strategies
Drug Channels
Gross-to-Net Bubble Update: 2023 Pricing Realities at 10 Top Drugmakers
Drug Channels
Optimizing Product Commercialization in Today’s IDN Environment
Drug Channels
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating
Drug Channels
At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs
Drug Channels
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts
Drug Channels
Breaking Down Medication Access and Affordability Barriers
Drug Channels
Drug Channels News Roundup, June 2024: Cordavis Humira Update, OptumRx’s New Biosim Biz, Generic Drugs' Wild Ride, IRA Predictions, and Dr. G on Med School
Drug Channels
Meet the Four Executives Headlining the Drug Channels Leadership Forum
Drug Channels

Latest Jobs

Account Executive - Hospice
Freeman, Missouri, 64746
Agape Care Group
Account Executive - Hospice
Wellington, Missouri, 64097
Agape Care Group
Account Executive - Hospice
Napoleon, Missouri, 64074
Agape Care Group
Healthcare Sales Professional
Denton, Texas, Texas
Tris Pharma
Psychiatry Account Manager - Santa Monica, CA
Santa Monica, California
Lundbeck
Senior Account Consultant, Durysta - San Diego, CA
San Diego, California, California
AbbVie
Senior Account Consultant, Retina - Hartford, CT
New Haven, Connecticut, Connecticut
AbbVie
Oncology Specialist - New York City
New York City, New York
AbbVie
Associate Director, Strategic Account Manager, Southern California
Los Angeles, California, California
AbbVie
Oncology Specialist - LA West
Santa Monica, California
AbbVie
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information